Chinese companies have over the past five years obtained exclusive distribution rights in Taiwan for 29 percent of new pharmaceuticals, the Legislative Yuan said, urging the government to intervene, as it said the issue extends far beyond Chinese agency over the Pfizer-BioNTech COVID-19 vaccine.
Right of agency for drug distribution has received widespread attention this year, after Germany’s BioNTech inked a deal with Shanghai Fosun Pharmaceutical Group (上海復星醫藥集團) to develop and distribute its COVID-19 vaccine in Taiwan, China, Hong Kong and Macau.
This has complicated Taipei’s efforts to procure the vaccine.
Private entities have stepped in to purchase doses to donate to the government, including Taiwan Semiconductor Manufacturing Co (台積電), the Buddhist Compassion Relief Tzu Chi Foundation and the Hon Hai Precision Industry Co (鴻海精密)-affiliated Yonglin Foundation.
In a report dated Monday, the Legislative Yuan’s Judiciary and Organic Laws and Statutes Bureau decried the arrangement as unreasonable.
“Requiring South Korea to purchase vaccines through a North Korean distributor or Israel to go through a Palestinian firm would be preposterous,” the report said.
Granting exclusive distribution rights in a nation to its political and military adversary is ethically problematic, it said.
Due to the antagonism and mutual distrust between the two nations, it is highly unlikely that they would complete a contract and instead use it as a tool for political manipulation, it added.
This would further hinder transactions and jeopardize the right to healthcare of the “represented country,” the report added.
Right of agency over pharmaceuticals has long been an issue, the bureau said.
Over the past five years, Chinese firms have obtained exclusive distribution rights to Taiwan for 29 percent of new pharmaceuticals, posing an increasingly serious problem that cannot be ignored, it said.
The bureau recommended that the Ministry of Foreign Affairs and national security agencies intervene in China’s attempts to monopolize Taiwan’s pharmaceutical market.
Using appropriate channels, officials should persuade multinationals to avoid signing right-of-agency contracts for Taiwan with Chinese distributors, thereby preventing human rights, moral and political controversies, it said.
All import licensing procedures should follow WTO protocols, as Taiwan, Germany and China are all members of the global trade body, the report added, recommending that the Ministry of Economic Affairs seek a decision from the WTO or another international economic forum to ensure fair and timely access to vaccines worldwide.
WAITING GAME: The US has so far only offered a ‘best rate tariff,’ which officials assume is about 15 percent, the same as Japan, a person familiar with the matter said Taiwan and the US have completed “technical consultations” regarding tariffs and a finalized rate is expected to be released soon, Executive Yuan spokeswoman Michelle Lee (李慧芝) told a news conference yesterday, as a 90-day pause on US President Donald Trump’s “reciprocal” tariffs is set to expire today. The two countries have reached a “certain degree of consensus” on issues such as tariffs, nontariff trade barriers, trade facilitation, supply chain resilience and economic security, Lee said. They also discussed opportunities for cooperation, investment and procurement, she said. A joint statement is still being negotiated and would be released once the US government has made
NEW GEAR: On top of the new Tien Kung IV air defense missiles, the military is expected to place orders for a new combat vehicle next year for delivery in 2028 Mass production of Tien Kung IV (Sky Bow IV) missiles is expected to start next year, with plans to order 122 pods, the Ministry of National Defense’s (MND) latest list of regulated military material showed. The document said that the armed forces would obtain 46 pods of the air defense missiles next year and 76 pods the year after that. The Tien Kung IV is designed to intercept cruise missiles and ballistic missiles to an altitude of 70km, compared with the 60km maximum altitude achieved by the Missile Segment Enhancement variant of PAC-3 systems. A defense source said yesterday that the number of
‘CRUDE’: The potential countermeasure is in response to South Africa renaming Taiwan’s representative offices and the insistence that it move out of Pretoria Taiwan is considering banning exports of semiconductors to South Africa after the latter unilaterally downgraded and changed the names of Taiwan’s two representative offices, the Ministry of Foreign Affairs (MOFA) said yesterday. On Monday last week, the South African Department of International Relations and Cooperation unilaterally released a statement saying that, as of April 1, the Taipei Liaison Offices in Pretoria and Cape Town had been renamed the “Taipei Commercial Office in Johannesburg” and the “Taipei Commercial Office in Cape Town.” Citing UN General Assembly Resolution 2758, it said that South Africa “recognizes the People’s Republic of China (PRC) as the sole
Taiwanese exports to the US are to be subject to a 20 percent tariff starting on Thursday next week, according to an executive order signed by US President Donald Trump yesterday. The 20 percent levy was the same as the tariffs imposed on Vietnam, Sri Lanka and Bangladesh by Trump. It was higher than the tariffs imposed on Japan, South Korea and the EU (15 percent), as well as those on the Philippines (19 percent). A Taiwan official with knowledge of the matter said it is a "phased" tariff rate, and negotiations would continue. "Once negotiations conclude, Taiwan will obtain a better
RSS